Jilifen is indicated for neutropenia inducted by anti-cancer chemotherapy and various other causes. For patients receiving myelosuppressive cheomtherapy especically intensive, myeloablative chemotherapy, Jilifen injection can prevent neutropenia and accelerate the recovery of neutrophils. As a result,the risk of complication with infection is decreased.
Dosage form: ampoule/ Pre-filled syringe.
Specification: 75ug,150ug,300ug.
Hangzhou Jiuyuan Gene Engineering Co. Ltd., located in Hangzhou Economic & Technological Development Zone, is a modern pharmaceutical enterprise specializing in research, development, production and sales of gene engineering and biochemical medicines. Founded in 1993, the company occupies an area of 3. 34 hectares, of which 47% are greenery area.
The factory buildings of 7, 000 M2 were constructed in accordance with GMP standard and passed the GMP authentication of State Drug Administration in 1999. In 1996, Jiuyuan firstly developed a white blood cell promotion medicine in China-recombinant human granulocyte colonystimulating factor injection. In 1997, Jiuyuan firstly developed a thrombosis preventing medicine-low molecular weight heparin sodium injection.
Based on advanced technology and first-class talents with rich experience accumulated in recent 9 years, our company now has possessed the capacity of developing novel gene engineering medicine. Its research work has extended to separation of Chinese traditional medicines' active components, computer-aided drug design, slow-release of protein medicines and gene engineering antibodies. In order to reach international level, Jiuyuan accepted many scholars returning from abroad and talents from foreign enterprise. They work with the founders of the Jiuyuan together to write a new chapter of the Jiuyuan soaring.
